Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Prana Biotechnology
Prana Biotechnology
Huntington’s Disease Orphan Drug Designation Could Rescue Prana Read more: Huntington's Disease Orphan Drug Designation Could
24/7 Wall St
Fri, 09/5/14 - 03:59 pm
Huntington's disease
orphan drugs
Prana Biotechnology
Prana Alzheimer's Study Fails
TheStreet.com
Mon, 03/31/14 - 09:38 am
Prana Biotechnology
Alzheimer's disease
PBT2
The Best- And Worst-Performing Biotech Stocks, Feb. 21 to Feb. 28
Forbes
Mon, 03/3/14 - 08:12 am
InterMune
Prana Biotechnology
Cara Therapeutics
Prothena
Endologix
Ampio Pharmaceuticals
Questcor Pharmaceuticals
Aegerion
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results
Seeking Alpha
Sat, 03/1/14 - 11:58 am
Alzheimer's disease
Prana Biotechnology
PBT2
Prana Biotechnology Faces Major Upcoming Catalysts
Wall St Cheat Sheet
Fri, 01/24/14 - 12:11 pm
Prana Biotechnology
PBT2
Huntington's disease
Alzheimer's disease
brain cancer
Parkinson's Disease
PBT434
PBT519
The Past, Present, and Future of Alzheimer’s Treatments
Motley Fool
Fri, 08/23/13 - 09:26 am
Alzheimer's disease
Aricept
Pfizer
Eisai
Actavis
Namenda
Eli Lilly
Forest Labs
bapineuzumab
JNJ
Elan
Perrigo Company
solanezumab
PBT2
Prana Biotechnology